Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,291.20
(
0.66%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.50
(
-0.15%
)
Bitcoin
74,225.69
(
0.39%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jq1234

Send PM Follow Ignore
Followers 69
Posts 4516
Boards Moderated 0
Alias Born 12/13/2009

jq1234

Re: DewDiligence post# 150057

Thursday, 10/04/2012 10:31:44 PM

Thursday, October 04, 2012 10:31:44 PM

Post# of 257253
This is for RA only according to BioCentury. I don't know if it applies to oncology also.

http://www.biocentury.com/dailynews/topstory/2012-10-04/teva-no-trial-yet-for-biosimilar-rituximab

Here is the EU trial prematurely ended:

https://www.clinicaltrialsregister.eu/ctr-search/search?query=tl011
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now